The Journal of Practical Medicine >

2023 , Vol. 39 >Issue 17: 2176 - 2182

DOI: https://doi.org/10.3969/j.issn.1006-5725.2023.17.005

Basic Research

Preliminary study on the mechanism of TMEM39A in primary biliary cholangitis

  • Xiaotong SUN ,
  • Chongxu HAN ,
  • Chan WANG ,
  • Chuanli REN ,
  • Mingming. ZHANG
Expand
  • Medical College of Yangzhou University，Yangzhou 225009，China

Received date: 2023-03-27

  Online published: 2023-09-27

Fold

Abstract

Objective To explore the mechanism of TMEM39A in primary biliary cholangitis. Method In order to study how TMEM39A regulates the expression of autophagy in primary biliary cholangitis， human hepatobiliary cancer cell RBE was selected for study. Human hepatobiliary cancer cells were treated with the hydrophobic bile acid glycine deoxycholic acid （GCDC） into three groups： control group， 500 μmol/L group and 1 000 μmol/L group. Cell counting kits （CCK-8）， cell cloning， cell scratching， and Hoechst staining assays were used to detect cell viability， proliferation， wound healing rates， and apoptosis. qPCR detected TMEM39A mRNA expression in cells； Western Blot detects protein expression of TMEM39A and LC3. Results Compared with control group， cell viability， proliferation and wound healing rate were decreased in 1 000 μmol/L group， while apoptosis was the most obvious. In the constructed model of primary biliary cholangitis， overexpression of TMEM39A promoted LC3 expression. Conclusion The increased expression of TMEM39A leads to enhanced autophagy of bile duct cells and bile duct damage， which may be one of the mechanisms causing primary biliary cholangitis.

Key words： TMEM39A; primary biliary cholangitis; human hepatobiliary duct cancer cells; LC3; glycochenodeoxycholic acid

Cite this article

Xiaotong SUN , Chongxu HAN , Chan WANG , Chuanli REN , Mingming. ZHANG . Preliminary study on the mechanism of TMEM39A in primary biliary cholangitis[J]. The Journal of Practical Medicine, 2023 , 39(17) : 2176 -2182 . DOI: 10.3969/j.issn.1006-5725.2023.17.005

References

1 PRIETO J， BANALES J M， MEDINA J F. Primary biliary cholangitis： pathogenic mechanisms ［J］. Curr Opin Gastroenterol， 2021， 37（2）： 91-98.
2 TANAKA A. Current understanding of primary biliary cholangitis ［J］. Clin Mol Hepatol， 2021， 27（1）： 1-21.
3 LEUNG K K， DEEB M， HIRSCHFIELD G M. Review article： pathophysiology and management of primary biliary cholangitis ［J］. Aliment Pharmacol Ther， 2020， 52（7）： 1150-1164.
4 TANAKA A， LEUNG P S C， GERSHWIN M E. Evolution of our understanding of PBC ［J］. Best Pract Res Clin Gastroenterol， 2018， 34-35： 3-9.
5 CHASCSA D M H， LINDOR K D. Emerging therapies for PBC ［J］. J Gastroenterol， 2020， 55（3）： 261-272.
6 PHAW N A， DYSON J K， JONES D. Emerging drugs for the treatment of primary biliary cholangitis ［J］. Expert Opin Emerg Drugs， 2020， 25（2）： 101-112.
7 党富涛， 唐谭绪，徐加敏. 原发性胆汁性胆管炎患者中人工肝支持系统的应用 ［J］. 实用医学杂志， 2020， 36（22）： 3153-3156.
8 TRAN Q， PARK J， LEE H， et al. TMEM39A and Human Diseases： A Brief Review ［J］. Toxicol Res， 2017， 33（3）： 205-209.
9 MIAO G， ZHANG Y， CHEN D， et al. The ER-Localized Transmembrane Protein TMEM39A/SUSR2 Regulates Autophagy by Controlling the Trafficking of the PtdIns（4）P Phosphatase SAC1 ［J］. Mol Cell， 2020， 77（3）： 618-632.e615.
10 QIU F， TANG R， ZUO X，et al. A genome-wide association study identifies six novel risk loci for primary biliary cholangitis ［J］. Nat Commun， 2017， 8： 14828.
11 SASAKI M， MIYAKOSHI M， SATO Y， et al. Autophagy may precede cellular senescence of bile ductular cells in ductular reaction in primary biliary cirrhosis ［J］. Dig Dis Sci， 2012， 57（3）： 660-666.
12 LI H， GUAN Y， HAN C，et al. The pathogenesis， models and therapeutic advances of primary biliary cholangitis ［J］. Biomed Pharmacother， 2021， 140： 111754.
13 TANAKA A， LEUNG P S C， GERSHWIN M E. The genetics of primary biliary cholangitis ［J］. Curr Opin Gastroenterol， 2019， 35（2）： 93-98.
14 ASEEM S O， HYLEMON P B， ZHOU H. Bile Acids and Biliary Fibrosis ［J］. Cells， 2023， 12（5）：792.
15 HOFMANN A F， HAGEY L R， KRASOWSKI M D. Bile salts of vertebrates： structural variation and possible evolutionary significance ［J］. J Lipid Res， 2010， 51（2）： 226-246.
16 CHIANG J Y L， FERRELL J M. Bile Acids as Metabolic Regulators and Nutrient Sensors ［J］. Annu Rev Nutr， 2019， 39： 175-200.
17 WOOLBRIGHT B L， DORKO K， ANTOINE D J， et al. Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis ［J］. Toxicol Appl Pharmacol， 2015， 283（3）： 168-177.
18 KLIONSKY D J， PETRONI G， AMARAVADI R K，et al. Autophagy in major human diseases ［J］. Embo J， 2021， 40（19）： e108863.
19 PANZITT K， FICKERT P， WAGNER M. Regulation of autophagy by bile acids and in cholestasis - CholestoPHAGY or CholeSTOPagy ［J］. Biochim Biophys Acta Mol Basis Dis， 2021， 1867（2）： 166017.
20 SASAKI M， MIYAKOSHI M， SATO Y， et al. Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis ［J］. Lab Invest， 2010， 90（6）： 835-843.
21 SASAKI M， NAKANUMA Y. Bile Acids and Deregulated Cholangiocyte Autophagy in Primary Biliary Cholangitis ［J］. Dig Dis， 2017， 35（3）： 210-216.
22 LUO S， WANG X， BAI M， et al. The conserved autoimmune-disease risk gene TMEM39A regulates lysosome dynamics ［J］. Proc Natl Acad Sci U S A， 2021， 118（6）：e2011379118.
Options
Outlines

/

〈 〉